Carpal tunnel syndrome (CTS) is a common form of hand mononeuropathy that is typi-cally caused by median nerve compression. Although it is often idiopathic, CTS can also result from various conditions, including space-occupying lesions. Tumoral calcinosis, a rare condition characterized by periarticular deposition of calcified masses, is an un-common cause of secondary CTS. We present a case of a 78-year-old woman with idio-pathic tumoral calcinosis that caused secondary CTS. Despite conservative treatments, her symptoms persisted, and diagnostic imaging, including radiographs, computed to-mography, and magnetic resonance imaging, revealed a calcified mass in the carpal tun-nel. A surgical intervention involving carpal tunnel release and excisional biopsy con-firmed the diagnosis of tumoral calcinosis. Postoperatively, the patient showed complete resolution of symptoms, with no recurrence on follow-up radiographs. This case high-lights the importance of considering space-occupying lesions, such as tumoral calcinosis, as a rare but treatable cause of secondary CTS.

Objective: Preterm births in the late preterm period comprise more than half of all preterm births. However, perinatal outcome evaluation between singleton and multiple pregnancies is limited. This study aimed to compare the perinatal outcomes of preterm pre-labor rupture of membranes (PPROM) between twin and singleton pregnancies at 34 weeks to 36 weeks and 6 days. Methods: This retrospective case-control study included women with preterm births at the Tertiary Hospital between July 2006 and December 2023. We analyzed and compared the maternal and neonatal characteristics, especially intertwined neonatal morbidity and mortality, with those of singletons. Results: There were 52 twin and 317 singleton pregnancies. Women with twin pregnancies had shorter median latencies and fewer cases of histological chorioamnionitis than those with singleton pregnancies. Compared to the ruptured sac babies of twins and singletons, unruptured sac babies of twins had longer hospital stays and were more likely to require respiratory support and resuscitation immediately after delivery. Conclusion Maternal outcomes of twins and singletons after PPROM differed in latency and histologic chorioamnionitis, whereas neonatal outcomes demonstrated more acute respiratory problems and longer hospital stays in twin babies with unruptured sacs. More cautious respiratory care is needed for infants with an unruptured sac immediately after birth.

Objective: Preterm births in the late preterm period comprise more than half of all preterm births. However, perinatal outcome evaluation between singleton and multiple pregnancies is limited. This study aimed to compare the perinatal outcomes of preterm pre-labor rupture of membranes (PPROM) between twin and singleton pregnancies at 34 weeks to 36 weeks and 6 days. Methods: This retrospective case-control study included women with preterm births at the Tertiary Hospital between July 2006 and December 2023. We analyzed and compared the maternal and neonatal characteristics, especially intertwined neonatal morbidity and mortality, with those of singletons. Results: There were 52 twin and 317 singleton pregnancies. Women with twin pregnancies had shorter median latencies and fewer cases of histological chorioamnionitis than those with singleton pregnancies. Compared to the ruptured sac babies of twins and singletons, unruptured sac babies of twins had longer hospital stays and were more likely to require respiratory support and resuscitation immediately after delivery. Conclusion Maternal outcomes of twins and singletons after PPROM differed in latency and histologic chorioamnionitis, whereas neonatal outcomes demonstrated more acute respiratory problems and longer hospital stays in twin babies with unruptured sacs. More cautious respiratory care is needed for infants with an unruptured sac immediately after birth.

Background: The US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approved empagliflozin for reducing cardiovascular mortality and heart failure (HF) hospitalization in patients with both HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF). However, limited data are available on the generalizability of empagliflozin to clinical practice. Therefore, we evaluated real-world eligibility and potential cost-effectiveness based on a nationwide prospective HF registry. Methods: A total of 3,108 HFrEF and 2,070 HFpEF patients from the Korean Acute Heart Failure (KorAHF) registry were analyzed. Eligibility was estimated by inclusion and exclusion criteria of EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) and EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) trials and by FDA & EMA label criteria. The cost-utility analysis was done using a Markov model to project the lifetime medical cost and quality-adjusted life year (QALY). Results: Among the KorAHF patients, 91.4% met FDA & EMA label criteria, while 44.7% met the clinical trial criteria. The incremental cost-effectiveness ratio of empagliflozin was calculated at US$6,764 per QALY in the overall population, which is far below a threshold of US$18,182 per QALY. The cost-effectiveness benefit was more evident in patients with HFrEF (US$5,012 per QALY) than HFpEF (US$8,971 per QALY). Conclusion There is a large discrepancy in real-world eligibility for empagliflozin between FDA & EMA labels and clinical trial criteria. Empagliflozin is cost-effective in HF patients regardless of ejection fraction in South Korea health care setting. The efficacy and safety of empagliflozin in real-world HF patients should be further investigated for a broader range of clinical applications.

Background: Inter-hospital transfers of severely injured patients are inevitable due to limited resources. We investigated the association between inter-hospital transfer and the prognosis of pediatric injury using the Korean multi-institutional injury registry. Methods: This retrospective observational study was conducted from January 2013 to December 2017; data for hospitalized subjects aged < 18 years were extracted from the Emergency Department-based Injury in Depth Surveillance database, in which 22 hospitals are participating as of 2022. The survival rates of the direct transfer group and the interhospital transfer group were compared, and risk factors affecting 30-day mortality and 72-hour mortality were analyzed. Results: The total number of study subjects was 18,518, and the transfer rate between hospitals was 14.5%. The overall mortality rate was 2.3% (n = 422), the 72-hour mortality was 1.7% (n = 315) and the 30-day mortality rate was 2.2% (n = 407). The Kaplan-Meier survival curve revealed a lower survival rate in the inter-hospital transfer group than in the direct visit group (log-rank, P < 0.001). Cox proportional hazards regression analysis showed that interhospital transfer group had a higher 30-day mortality rate and 72-hour mortality (hazard ratio [HR], 1.681; 95% confidence interval [CI], 1.232–2.294 and HR, 1.951; 95% CI, 1.299–2.930) than direct visit group when adjusting for age, sex, injury severity, and head injury. Conclusion Among the pediatric injured patients requiring hospitalization, inter-hospital transfer in the emergency department was associated with the 30-day mortality rate and 72-hour mortality rate in Korea.